Stroke is a leading cause of disability and death worldwide. Early recognition and prompt management can significantly improve patient outcomes. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Stroke symptoms often appear suddenly. The FAST (Face drooping, Arm weakness, Speech difficulties, Time to call emergency services) acronym is a well-known tool for recognizing stroke symptoms. However, other symptoms such as confusion, vision disturbances, and balance or coordination problems may also be indicative of a stroke.
Upon suspecting a stroke, immediate diagnostic measures should be taken. A CT scan or MRI of the brain is often the first step to confirm the diagnosis and differentiate between ischemic and hemorrhagic stroke. Additional tests like blood tests, carotid ultrasound, or cerebral angiogram may be required to identify the cause of the stroke.
Once a stroke is confirmed, swift initiation of treatment is crucial. For ischemic stroke, intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) can be given within 4.5 hours of symptom onset. In some cases, endovascular procedures may be considered. Hemorrhagic stroke management focuses on controlling bleeding and reducing pressure in the brain.
After initial management, secondary prevention strategies should be implemented to prevent recurrent strokes. This includes control of risk factors such as hypertension, diabetes, and atrial fibrillation, lifestyle modifications, and potentially antithrombotic therapy.
Early recognition and prompt management of stroke can significantly alter patient outcomes. As healthcare professionals, staying abreast of the latest diagnostic and treatment strategies is vital for providing optimal patient care in these critical situations.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation